Conatus Pharmaceuticals (CNAT) null Earnings

7AugConfirmed
Nov 18
Mar 19
May 19
Aug 19
-0.15
-0.11
-0.06
-0.02

Details

Expected EPS
-0.12
Actual EPS
-0.02
Surprise EPS
0.1
Surprise Percent
+83.33%

Description

Conatus Pharmaceuticals (CNAT) has reported earnings of -0.02 per share for .

0 Comments

Share your thoughts